The correlation of TERT expression with c-myc expression in cervical cancer

Cancer Letters

Volumn 168, Issue 1, 2001, Pages 45-50

  Sagawa, Yasukazu ^a   Nishi, Hirotaka ^a   Isaka, Keiichi ^a   Fujito, Atsuya ^a   Takayama, Masaomi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

c myc; Cervical cancer; Telomerase; Telomerase reverse transcriptase

Indexed keywords

PROTEIN SUBUNIT; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA;

CERVIX UTERI; DNA-BINDING PROTEINS; FEMALE; HELA CELLS; HUMANS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TELOMERASE; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0035838588     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00501-8     Document Type: Article

References (28)

1. Nelson N.J. Researchers debate clinical role of telomerase activity. J. Ntl. Cancer Ins. 88:1996;1021-1023.
2. Greider C.W., Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 337:1989;331-337.
3. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA. 89:1992;10114-10118.
4. Shay J.W., Wright W.E. Telomerase activity in human cancer. Curr. Opin. Oncol. 8:1996;66-71.
5. Holt S.E., Shay J.W., Wright W.E. Refining the telomere-telomerase hypothesis of aging and cancer. Nature Biotechnol. 14:1996;1-5.
6. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
7. Ohyashiki J.H., Ohyashiki K., Sano T., Toyama K. Non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Jpn. J. Cancer Res. 87:1996;329-331.
8. Bacchetti S., Counter C.M. Telomeres and telomerase in human cancer. Int. J. Oncol. 7:1995;423-432.
9. Shay J.W., Gazdar A.F. Telomerase in the early detection of cancer. J. Clin. Pathol. 50:1997;106-109.
10. Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M.A., Shay J.W., Ishioka S., Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:1995;3711-3715.
11. Terasawa K., Sagae S., Takeda T., Ishioka S., Kobayashi K., Kudo R. Telomerase activity in malignant ovarian tumors with deregulation of cell cycle regulatory proteins. Cancer Lett. 142:1999;207-217.
12. Nishi H., Yahata N., Ohyashiki K., Isaka K., Shiraishi J.H., Ohyashiki K., Toyama M. Comparison of telomerase activity in normal chorionic villi to trophoblastic diseases. Int. J. Oncol. 12:1998;81-85.
13. Kyo S., Kanaya T., Ishikawa H., Ueno H., Inoue M. Telomerase activity in gynecological tumors. Clin. Cancer Res. 2:1996;2023-2028.
14. Kyo S., Takakura M., Tanaka M., Kanaya T., Inoue M. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int. J. Cancer. 79:1998;66-70.
15. Nagai N., Oshita T., Murakami J., Ohama K. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions. Oncol. Rep. 6:1999;325-328.
16. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J., Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., Villeponteau B. The RNA component of human telomerase. Science. 269:1995;1236-1241.
17. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
18. Nakayama J., Saito M., Nakamura H., Matsuura A., Ishikawa F. TLP1 a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 88:1997;875-884.
19. Takakura M., Kyo S., Kanaya T., Tanaka M., Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 58:1998;1558-1561.
20. Yasui W., Tahara H., Tahara E., Fujimoto J., Nakayama J., Ishikawa F., Ide T., Tahara E. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas. Jpn. J. Cancer Res. 89:1998;1099-1103.
21. Nishi H., Ohyashiki K., Fujito A., Yahata N., Ohyashiki J.H., Isaka K., Takayama M. Expression of telomerase subunits and localization of telomerase activation in hydatidiform mole. Placenta. 20:1999;317-323.
22. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., Ishikawa F. Telomerase activation by TERT in human normal fibroblasts and hepatocellular carcinomas. Nature Genet. 18:1998;65-68.
23. Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M., Inoue M. Cloning of human telomerase catalytic subunit (TERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59:1999;551-557.
24. Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat. Genet. 21:1999;220-224.
25. Greenberg R.A., O'Hagan R.C., Deng H., Xiao Q., Hann S.R., Adams R.R., Lichtsteiner S., Chin L., Morin G.B., DePinho R.A. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 18:1999;1219-1226.
26. Iwasaka T., Yokoyama M., Oh-uchida M., Matsuo N., Hara K., Fukuyama K., Hachisuga T., Fukuda K., Sugimori H. Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas. Gynecol. Oncol. 46:1992;298-303.
27. Nakano K., Watney E., McDougall J.K. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am. J. Pathol. 153:1998;857-864.
28. Latil A., Vidaud D., Valéri A., Fournier G., Vidaud M., Lidereau R., Cussenot O., Bièche I. htert expression correlates with MYC over-expression in human prostate cancer. Int. J. Cancer. 89:2000;172-176.